traZODone Hydrochloride Tablets — Class II drug recall D-0834-2026
Ongoing recall by Teva Pharmaceuticals USA, Inc, reported 2026-09-09, distributed nationwide. Presence of Foreign Tablets/Capsules
| Recall number | D-0834-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Teva Pharmaceuticals USA, Inc, Parsippany, NJ, United States |
| Recall initiated | 2026-08-24 |
| Classified | 2026-09-08 |
| Reported by FDA | 2026-09-09 |
| Distributed | Nationwide (US) |
| Quantity | 175,392 bottles |
| NDC | 50111-0450, 50111-0450-01, 50111-0450-02, 50111-0560, 50111-0560-01, 50111-0560-02, 50111-0560-03, 50111-0561, 50111-0561-01, 50111-0561-02, 50111-0561-03 |
| Lot numbers | 1394026 |
| Expiration dates | 2028-02 |
Product
traZODone Hydrochloride Tablets, USP, 50 mg, Rx only, 100 Tablets, Manufactured in Croatia By: Pliva Hrvatska d.o.o, Zagreb, Croatia, Manufactured For: Teva Pharmaceuticals, Parsippany, NJ 07054, NDC 50111-560-01
Reason for recall
Presence of Foreign Tablets/Capsules
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0834-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.